Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort

Affiliations

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas. Electronic address: hasheme@bcm.edu.
² Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
³ Department of Biostatistics, UT MD Anderson Cancer Center, Houston, Texas.
⁴ Division of Digestive and Liver Diseases, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.
⁵ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas.

Hashem B El-Serag et al. Gastroenterology. 2020 Jul.

. 2020 Jul;159(1):376-377.

doi: 10.1053/j.gastro.2020.03.049. Epub 2020 Mar 29.

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas. Electronic address: hasheme@bcm.edu.
² Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
³ Department of Biostatistics, UT MD Anderson Cancer Center, Houston, Texas.
⁴ Division of Digestive and Liver Diseases, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.
⁵ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas.

No abstract available

Keywords: Alcoholic Liver Disease; Cirrhosis; HCV Infection; Hepatocellular Carcinoma; Nonalcoholic Fatty Liver Disease.

Conflict of interest statement

Conflicts of Interest: The authors have no conflict of interest to declare.

1. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:k2817. - PMC - PubMed
1. Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology. 2017;153(4):996–1005. e1. - PubMed
1. El-Serag HB. Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels. Gastroenterology. 2018;155(3):607–9. - PMC - PubMed
1. Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, et al.Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. American Journal of Gastroenterology. 2019;114(3):530–2. - PMC - PubMed
1. White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology. 2017;152(4):812–20. e5. - PMC - PubMed